2.3. MTT cell viability assays

FC Fangli Chen
XW Xue Wu
CN Cristina Niculite
MG Marilena Gilca
DP Daniela Petrusca
AR Adriana Rogozea
SR Susan Rice
BG Bin Guo
SG Shawn Griffin
GC George A. Calin
HB H. Scott Boswell
HK Heiko Konig
request Request a Protocol
ask Ask a question
Favorite

1 × 104 Molm14, THP‐1 and OCI‐AML3 cells or 15 × 104 fresh primary cells suspended in RPMI 1640 culture medium with 10% FBS were seeded in 96‐well plates. Cells were treated with either drug in single agent or combined mode under ambient air (21% O2, normoxia) or hypoxic conditions (1% O2) for 48 hours as outlined for each experiment. Cell viability was assessed using MTT (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide; Roche) in accordance with the manufacturer's recommended protocols. Briefly, 20 µL MTT solution was added into each well and incubated at 37°C for 2 hours. Plates were read on at 490 nm with a plate reader. Growth inhibition percentage was calculated from the optical density ratio of treatment to DMSO control after subtraction of background under 21% O2 and 1% O2, respectively. All assays were performed in triplicate, and the results were obtained in at least three independent experiments as outlined for each experiment. Combination indexes (CIs) were determined using CompuSyn software.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A